Global gRNA Market Projected at $2.95B by 2034, 19% CAGR (A)
What happened
A third-party analysis from Custom Market Insights projects the global guide RNA market will reach approximately $2.95 billion by 2034, expanding at a 19% compound annual growth rate. The report covers competitive landscape, regional segmentation, and demand trends across the gRNA tools and reagents space. Agilent Technologies (A), a life sciences instrumentation and reagents provider, operates within the broader genomics tools ecosystem addressed by the report.
The QL Read
With market breadth at 43.8% advancing and the tape leaning risk-off, industry tailwind data alone carries limited near-term weight. Agilent's composite signal holds at 62/100 (Buy), suggesting the engine sees underlying support despite the soft broader tape.
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.